Sponsors

Lead Sponsor

University Hospital Schleswig-Holstein

Collaborators

German Research Foundation
Roche Diagnostics GmbH
University of Luebeck

Children and adolescents currently treated with MDI and with an indication for CSII were randomized 1:1 to either starting with CSII as soon as possible or to continuing MDI while waiting six months for transmission to CSII, stratified by center. The primary outcomes were patient-reported diabetes-specific health-related quality of life , and diabetes burden of the main caregiver. We also investigated the impact of CSII on main caregiver stress, psychological well-being, fear of hypoglycemia, main caregiver's and adolescent's treatment satisfaction, family conflict, and HbA1c.

Related studies

RECRUITINGNA

Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM)

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)

SteadiSet™ Pilot Study (SteP Study)

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

Trial snapshot

Condition

Locations shown

For caregivers